The effects of octreotide on GH receptor and IGF-I expression in the GH-deficient rat

Journal of Endocrinology

Volumn 149, Issue 2, 1996, Pages 223-231

  Ambler, G R ^a,b   Butler, A A ^a   Padmanabhart, J ^a   Breier, B H ^a   Gluckman, P D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; MESSENGER RNA; OCTREOTIDE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GROWTH HORMONE DEFICIENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029946671     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1490223     Document Type: Article

References (44)

1. Adamo ML, Ben Hur H, Roberts CT Jr & LeRoith D 1991 Regulation of start site usage in the leader exons of the rat insulin-like growth factor-I gene by development, fasting, and diabetes. Molecular Endocrinology 5 1677-1686.
2. Baumbach WR, Horner DL & Logan JS 1989 The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes and Development 3 1199-1205.
3. Baxter RC, Bryson JM & Turtle JR 1981 The effects of fasting on liver receptors for prolactin and growth hormone. Metabolism 30 1086-1090.
4. Breier BH, Gluckman PD, Blair HT & McCutcheon SN 1989 Somatotrophic receptors in hepatic tissue of the developing pig. Journal of Endocrinology 123 25-31
5. Breier BH, Gallaher BW & Gluckman PD 1991 Radioimmunoassay for insulin-like growth factor-1: solutions to some potential problems and pitfalls. Journal of Endocrinology 128 347-357.
6. Carmignac DF & Robinson ICAF 1990 Growth hormone (GH) secretion in the dwarf rat release, clearance and responsiveness to GH-releasing factor and somatostatin. Journal of Endocrinology 127 69-75
7. Charlton HM, Clark RG, Robinson CAF, Porter Goff AE, Cox BS, Bugnon C & Bloch BA 1988 Growth hormone-deficient dwarfism in the rat: a new mutation. Journal of Endocrinology 119 51-58
8. Chomczynski P & Sacchi N 1987 Single-step method of RNA isolation by acid guanidimum thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 156-159.
9. Ezzat S, Son-Guang R, Braunstein GD & Melmed S 1992 Octreotide stimulates insulin-like growth factor-binding protein-1: a potential pituitary-independent mechanism for drug action. Journal of Clinical Endocrinology and Metabolism 75 1459-1463.
10. Fliesen T, Maiter D, Gerard G, Underwood LE, Maes M & Ketelslegers JM 1989 Reduction of serum insulin-like growth factor-I by dietary protein restriction is age-dependent. Pediatric Research 26 415-419.
11. Flyvbjerg A, Jorgensen KD, Marshall SM & Orskav H 1991 Inhibitory effect of octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats. American Journal of Physiology 260 E568-E574.
12. Gallaher BW, Breier BH, Oliver MH, Harding JE & Gluckman PD 1992 Ontogenic differences in the nutritional regulation of circulating IGF binding proteins in sheep plasma. Acta Endocrinologica 126 49-54.
13. Gluckman PD & Breier BH 1988 The regulation of the growth hormone receptor. In Biotechnology in Growth Regulation, pp 27-33. Eds RB Heap, CG Prosser & GE Lamming. London: Butterworths.
14. Green DW, Gomez G & Greeley GH 1989 Gastrointestinal peptides. Gastroenterology Clinics of North America 18 695-733.
15. Harrison SM, Barnard R, Ho KY, Rajkovic I & Waters MJ 1995 Control of growth hormone (GH) binding protein release from human hepatoma cells expressing full-length GH receptor. Endocrinology 136 651-659.
16. Heinrichs C, Yanovski JA, Roth AH, Yu YM, Domene HM, Yano K, Cutler GB Jr & Baron J 1994 Dexamethasone increases growth hormone receptor messenger ribonucleic acid levels in liver and growth plate. Endocrinology 135 1113-1118.
17. Lamberts SW, Krenning EP & Reubi JC 1991 The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrine Reviews 12 450-482.
18. Lamberts SW, Reubi JC & Krenning EP 1992 Somatostatin analogs in the treatment of acromegaly. Endocrinology and Metabolism Clinics of North America 21 737-752.
19. Lemaire M, Azria M, Danneker R, Marbach P, Schweitzer A & Maurer G 1989 Disposition of sandostatin, a new synthetic somatostatin analogue, in rats. Drug Metabolism and Disposition: The Biological Fate of Chemicals 17 699-703.
20. LeRoith D & Roberts CT 1991 Insulin-like growth factor I (IGF-I): a molecular basis for endocrine versus local action? Molecular and Cellular Endocrinolgy 77 C57-C61.
21. LeRoith D, Adamo M, Werner H & Roberts CT Jr 1991 Insulin-like growth factors and their receptors in normal physiology and pathological states. Trends in Endocrinology and Metabolism 2 134-139.
22. Lowe WL Jr, Roberts CT Jr, Lasky SR & LeRoith D 1987 Differential expression of alternative 5′ untranslated regions in mRNAs encoding rat insulin-like growth factor I. Proceedings of the National Academy of Sciences of the USA 84 8946-8950.
23. Lowe WL Jr, Lasky SR, LeRoith D & Roberts CT Jr 1988 Distribution and regulation of rat insulin-like growth factor I messenger ribonucleic acids encoding alternative carboxytermmal E-peptides: evidence for differential processing and regulation in liver. Molecular Endocrinology 2 528-535.
24. Lowry OH, Rosebrough NJ, Farr AL & Randall RJ 1951 Protein measurement with the Folin phenol reagent Journal of Biological Chemistry 193 265-275.
25. Luo J & Murphy LJ 1989 Dexamethasone inhibits growth hormone induction of insulin-like growth factor-1 (IGF-1) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-1 mRNA abundance in the intact rats. Endocrinology 125 165-171.
26. Maes M, Underwood LE & Ketelslegers JM 1983 Plasma somatomedin-C in fasted and refed rats: close relationship with changes in liver somatogenic but not lactogenic binding sites. Journal of Endocrinology 97 243-252.
27. Murphy LJ, Bell GI & Friesen HG 1987 Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat. Endocrinology 120 1279-1282.
28. Newman JB, Lluis F & Townsend CM 1987 Somatostatin In Gastrointestinal Endocrinology, pp 286-299. Eds JC Thompson, GH Greeley, PL Rayford & CM Townsend. New York. McGraw Hill Book Company
29. Niimi S, Hayakawa T & Tanaka A 1990 Hormonal regulation of growth hormone receptors in primary cultured rat hepatocytes Endocrinology 127 688-694.
30. Oliver MH, Harding JE, Breier BH, Evans PC & Gluckman PD 1993 Glucose but not amino acids regulates plasma insulin-like growth factor-I (IGF-I) concentrations in fetal sheep. Pediatric Research 34 62-65.
31. Postel-Vinay MC, Cohen-Tanugi E & Charrier J 1982 Growth hormone receptors in rat liver membranes: effects of fasting & refeeding and correlation with plasma somatomedin activity. Molecular and Cellular Endocrinology 28 667-672.
32. Quabbe H-J & Plockinger U 1989 Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly Journal of Clinical Endocrinology and Metabolism 68 873-881.
33. Read LC, Lemmey AB, Howarth GS, Martin AA, Tomas FM & Ballard FJ 1991 The gastrointestinal tract is one of the most responsive target tissues for IGF-1 and its potent analogs. In Modern Concepts of Insulin-Like Growth Factors, pp 225-234. Ed EM Spencer. New York: Elsevier Science Publishing Co Inc
34. Read LC, Tomas FM, Howarth GS, Martin AA, Edson KJ, Gillespie CM, Owens PC & Ballard FJ 1992 Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats. Journal of Endocrinology 133 421-431.
35. Salamon EA, Luo J & Murphy LJ 1989 The effect of acute and chronic insulin administration on insulin-like growth factor-I expression in the pituitary-intact and hypophysectomised rat. Diabetologia 32 348-353.
36. Sauerwein H, Breier BH, Bass JJ & Gluckman PD 1991 Chronic treatment with bovine growth hormone (bGH) up-regulates the high-affinity hepatic somatotrophic receptor in sheep. Acta Endocrinologica 124 307-313.
37. Serri O, Beauregard H, Brazeau P, Abribat T, Lambert J, Harris A & Vachon L 1991 Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes. Journal of the American Medical Association 265 888-892.
38. Serri O, Brazeau P, Kachra Z & Posner B 1992 Octreotide inhibits insulin-like growth factor-I hepatic gene expression in the hypophysectomized rat. evidence for a direct and indirect mechanism of action. Endocrinology 130 1816-1821.
39. Skottner A, Clark RG, Fryklund L & Robinson ICAF 1989 Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I. Endocrinology 124 2519-2526.
40. Song J, Xu Y, Bruno JF & Berelowitz M 1993 Tissue distribution of mRNA for somatostatin receptor subtypes in the rat. Endocrinology 133 2561-2567.
41. Tannenbaum GS, Rorstad O & Brazeau P 1979 Effects of prolonged food deprivation on the ultradian growth hormone rhythm and immunoreactive somatostatin tissue levels in the rat. Endocrinology 104 1733-1738.
42. Tauber JP, Babin T, Tauber MT, Vigoni F, Bonar A, Ducasse M, Harris AG & Bayard F 1989 Long term effects of continuous subcutaneous infusion of the somatostatin analog octreotide in the treatment of acromegaly. Journal of Clinical Endocrinology and Metabolism 68 917-924.
43. Thissen JP, Triest S, Underwood LE, Maes M & Ketelslegers JM 1990 Divergent responses of serum insulin-like growth factor-I and liver growth hormone (GH) receptors to exogenous GH in protein-restricted rats Endocrinology 126 908-913.
44. Zumkeller W 1992 Relationship between insulin-like growth factor-I and -II and IGF-binding proteins in milk and the gastrointestinal tract: growth and development of the gut. Journal of Pediatrics, Gastroenterology and Nutrition 15 357-369